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Abstract
Mycoplasma agalactiae is an important pathogen of small ruminants, in which it causes contagious agalactia. It belongs to a
large group of ‘‘minimal bacteria’’ with a small genome and reduced metabolic capacities that are dependent on their host
for nutrients. Mycoplasma survival thus relies on intimate contact with host cells, but little is known about the factors
involved in these interactions or in the more general infectious process. To address this issue, an assay based on goat
epithelial and fibroblastic cells was used to screen a M. agalactiae knockout mutant library. Mutants with reduced growth
capacities in cell culture were selected and 62 genomic loci were identified as contributing to this phenotype. As expected
for minimal bacteria, ‘‘transport and metabolism’’ was the functional category most commonly implicated in this
phenotype, but 50% of the selected mutants were disrupted in coding sequences (CDSs) with unknown functions, with
surface lipoproteins being most commonly represented in this category. Since mycoplasmas lack a cell wall, lipoproteins are
likely to be important in interactions with the host. A few intergenic regions were also identified that may act as regulatory
sequences under co-culture conditions. Interestingly, some mutants mapped to gene clusters that are highly conserved
across mycoplasma species but located in different positions. One of these clusters was found in a transcriptionally active
region of the M. agalactiae chromosome, downstream of a cryptic promoter. A possible scenario for the evolution of these
loci is discussed. Finally, several CDSs identified here are conserved in other important pathogenic mycoplasmas, and some
were involved in horizontal gene transfer with phylogenetically distant species. These results provide a basis for further
deciphering functions mediating mycoplasma-host interactions.
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Introduction
The term ‘‘mycoplasma’’ is used trivially to describe bacteria
belonging to the class Mollicutes, which includes the genus
Mycoplama, as well as several other related genera [1]. These
micro-organisms have evolved from a low G+C content Gram
positive ancestor by ‘‘regressive evolution’’, resulting in massive
genome reduction [2,3]. As a result, contemporary mycoplasmas
lack a cell-wall and are commonly described as the smallest self-
replicating organisms, because of the small size of their genome
(580 to 1,400 kbp) and the paucity of their metabolic pathways.
Mycoplasmas and ureaplasmas live in close contact with animal
tissues, probably because of their limited metabolic capacity, a
feature that is likely to have increased their dependence on hosts
for a number of nutrients [2]. Mycoplasmas occur widely in nature
and, despite their apparent simplicity, several species are successful
pathogens of animals, in which they establish persistent infections
and cause chronic disease [4].
Mycoplasma agalactiae is an important pathogen of small
ruminants that causes contagious agalactia (CA), resulting in
significant losses in the sheep and goat milk industries [5]. It is
classified by the World Organization for Animal Health (OIE) as a
notifiable disease and the clinical signs include mastitis, arthritis
and kerato-conjunctivitis [5]. Contagious agalactia is also caused
by several members of the mycoides cluster, including M. mycoides
subspecies mycoides Large Colony type and M. capricolum subspecies
capricolum [5]. Interestingly, while these mycoplasmas are phylo-
genetically distant from M. agalactiae, detailed in silico genomic
analyses have revealed that extensive horizontal gene transfer has
occurred between M. agalactiae and members of the mycoides
cluster, and as a result these mycoplasmas may share a number of
common cell surface functional domains [3,6]. Phylogenetically,
M. agalactiae is closely related to M. bovis [7], a pathogen of large
ruminants that causes clinical signs similar to those of contagious
agalactia [8]. For all these ruminant mycoplasmoses, the factors
involved in colonization, dissemination and pathogenicity are
poorly understood. As a number of genetic tools and genomic data
are available for M. agalactiae [6,9,10], this species is a useful model
for studying the molecular players involved in infectious processes
and thus furthering comprehension of pathogenic mechanisms in
other mycoplasmas.
A common approach used to identify virulence genes in
pathogenic bacteria is based on random transposon mutagenesis
[11–13]. In mycoplasmas, this approach has mainly been applied
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been successfully employed in a few cases to identify genes
potentially involved in pathogenicity [17], gliding motility and
adherence [18,19]. Such an approach is needed to further
understanding of M. agalactiae,a sin silico analyses of currently
available ruminant mycoplasma genomes has failed to reveal
unambiguously loci that might contribute to infection. Indeed,
predicted M. agalactiae gene products have little to no similarity to
virulence factors known in other bacteria, and 40% of the coding
sequences (CDSs) have been annotated as hypothetical proteins
with unknown functions [6]. For M. agalactiae and other ruminant
species, one limitation of global transposon mutagenesis to identify
virulence genes is the absence of a small laboratory animal model
of infection, as in vivo screening in the natural ruminant hosts is
constrained by both technical and ethical problems. To overcome
these issues, we developed a method for high-throughput screening
of M. agalactiae knockout mutants by co-cultivating M. agalactiae
mutants with HeLa cells [20]. This assay allowed the selection of a
number of genomic regions potentially required for growth in
HeLa cell cultures, but dispensable in axenic conditions. Human
epithelial surfaces are not a natural environment for M. agalactiae,
so we extended our functional genomic study by using two caprine
cell lines that are more relevant to the natural host context: goat
mammary epithelial cells, TIGMEC, which are likely to be good
targets based on the predilection of M. agalactiae for the mammary
gland, and goat embryo fibroblasts, TIGEF.
Over 2000 M. agalactiae mutants were co-cultured with caprine
cells and those showing a significant reduction in their capacity to
grow were examined in detail, revealing 62 loci potentially
required for propagation in the host environment. The relevance
of these loci and the potential role of the genes at these loci in M.
agalactiae-host interactions were analyzed.
Materials and Methods
Bacteria, cell lines and culture conditions
M. agalactiae reference strain PG2 (Refseq NC_009497) [6] was
grown in Aluotto or SP4 medium as described previously [20].
Titers were determined by serial dilution in Dulbecco’s phosphate-
buffered saline (Invitrogen) containing 1% heat-inactivated horse
serum (Invitrogen). E. coli DH10B (Invitrogen) was used for DNA
cloning and plasmid propagation. The human and caprine cell
lines used in this study included HeLa cells (ATCC CCL2), SV40
large T-antigen immortalized goat embryo fibroblasts (TIGEF)
and similarly immortalized goat mammary epithelial cells
(TIGMEC). TIGMEC were derived from milk epithelial cells
[21]. Immortalized cells exhibited morphological and phenotypic
features of parental milk epithelial cells and expressed cytokeratin,
a specific marker of epithelial cells. Immortalized goat embryo
fibroblasts were generated from carpal synovial membrane
explants and displayed morphological features of fibroblastic cells
[22]. Cells were grown in Dulbecco’s modified Eagle’s medium
(DMEM)-based medium, as described previously [20], composed
of DMEM (high glucose, sodium pyruvate, and GlutaMAX-I;
Invitrogen) supplemented with non-essential amino acids (NEAA;
Invitrogen) and 10% heat-inactivated fetal calf serum (FCS;
Eurobio).
M. agalactiae knockout mutant library
The library of knockout mutants was produced in M. agalactiae
reference strain PG2 [20]. Transposon mutagenesis was carried
out using plasmid pMT85, which does not replicate in
mycoplasmas, but contains a modified version of transposon
Tn4001 (mini-Tn) conferring gentamicin resistance [23]. Mutants
were collected from individual transformations to produce a
representative library of 2,175 individual mutants. The pMT85-
based library was propagated in SP4 medium supplemented with
500 mg cephalexin/ml (Virbac) and 50 mg gentamicin/ml (In-
vitrogen). Transposon insertion sites in the M. agalactiae chromo-
some were mapped by direct sequencing of the junction between
the M. agalactiae genomic DNA and the 39 end of the transposon
using BigDye Terminator chemistry and oligonucleotide primer
SG8 (Table 1). Direct sequencing was performed at the
sequencing facility at the Bio-Medical Research Federative
Institute of Toulouse (Toulouse, France). The 39 end of the
mini-Tn was defined using the orientation of the gentamicin
resistance gene as the reference [23]. The Pip, MucB and P40
minus mutants were identified by PCR screening of the mutant
library using specific oligonucleotide primers [20]. The mutants
NifS1 and NifS2 have been described previously as mutants 7.82
and 7.134, respectively [20]. These mutants had a mini-Tn
insertion at genomic positions 86804 (Pip), 88958 (MucB), 281483
(P40 minus), 87172 (NifS1) or 88125 (NifS2). The mini-Tn
gentamicin resistance gene in the NifS1, Pip, MucB and P40
minus mutants was in the opposite orientation compared to the
disrupted CDS, but in the same orientation in the NifS2 mutant.
High-throughput screening of M. agalactiae knockout
mutant library in cell culture
A cell-culture assay was used to screen the M. agalactiae knockout
mutant library and identify mutants displaying a growth-deficient
phenotype [20]. Briefly, cells seeded in 96-well plates were
inoculated with cultures of individual mutants using a 96-pin
replicator (Boekel Scientific). Growth-deficient mutants were
selected based on the titers reached at the end of the co-cultivation
period. After one freeze-thaw cycle (280uC/+37uC), co-cultures
were spotted onto solid medium using a 96-pin replicator. The
development of mycoplasma colonies was used as a cut-off point
(Table 2). Culture stocks (inoculum) of M. agalactiae knockout
mutants were tested by direct spotting onto solid medium. The
titer reached by the wild-type after co-cultivation with HeLa cells
[20], TIGMEC or TIGEF cells was not influenced by variations in
the initial inoculum size (data not shown). M. agalactiae was unable
to proliferate in cell-culture medium alone [20].
RNA extraction, RT-PCR amplification and primer
extension
Total RNA was extracted from 48 hour cultures of M. agalactiae
using the TRIzol method (Invitrogen). RNA samples were stored
at 280uC. The RNA concentration was determined spectropho-
tometrically by measuring absorbance at 260 nm and by agarose
gel electrophoresis. RT-PCRs were carried out with the Access
RT-PCR System kit (Promega), using 1 mg of total RNA treated
with DNAse (RNase-free DNAse, Promega). Reactions were
incubated at 45uC for 45 min, 94uC for 2 min, then through 30
cycles of 94uC for 30 sec, 56uC for 1 min and 72uC for 30 sec,
with a final extension incubation of 7 min at 72uC. Amplification
products were analyzed by agarose gel electrophoresis. Primer
extension was carried out using 15 mg of total RNA, 2 pmol of the
labeled oligonucleotide primer 59-6FAM-NifS1 (Table 1), and 200
units of Superscript III Reverse Transcriptase (Invitrogen). RNAs
were denatured by 5 min incubation at 65uC. Reverse transcrip-
tion reactions were performed at 42uC for 50 min, followed by
enzyme inactivation at 75uC for 15 min. The cDNAs were treated
with RNAse A (Promega) for 30 min at 37uC, ethanol precipitated
and resuspended in 10 ml formamide and 0.4 ml of GS-400HD
ROX size standards (Applied Biosystems). Product sizes were
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GenoToul genomic platform of Toulouse (France).
A reporter system for the detection of transcriptional
promoter sites in M. agalactiae
The surface antigen P40 CDS MAG2410 was used as a reporter
gene to assess transcriptional promoter activity in M. agalactiae.
DNA sequences to be tested were cloned upstream of CDS
MAG2410 using the plasmid p20-1miniO/T as a vector [20]. The
39 end of the pip gene was amplified by PCR using the primers Pip-
86804_F and Pip-P40_R (Table 1) to generate a 191 bp fragment
overlapping CDS MAG2410. CDS MAG2410 was amplified
using Pip-P40_F and CCP40-03 (Table 1) to generate a 1188 bp
fragment overlapping the 39 end of the pip gene. The two
overlapping fragments were assembled by PCR amplification
using the primers Pip-86804_F and CCP40-03 (Table 1). The
resulting PCR products were cloned into the pGEM-T Easy vector
(Promega), before sub-cloning into the NotI site of plasmid p20-
1miniO/T. PCR amplifications were performed using the
proofreading Phusion High Fidelity polymerase (Finnzymes).
Before cloning into pGEM-T Easy, 39-terminal deoxyadenosine
residues were added to blunt-ended PCR products by following
the A-tailing procedure provided by the supplier (Promega).
Cloned sequences were verified by DNA sequencing. CDS
MAG2410 alone or with its own promoter sequence was used as
negative and positive controls, respectively. PCR amplifications
were performed using primers P40_RF_CC and CCP40-03
(positive control), and Pip-P40_F and CCP40-03 (negative
control)(Table 1).
A surface antigen P40-knockout mutant (P40 minus; see above)
was used to test the expression of P40 from the different plasmid
constructs. M. agalactiae cells (10
8 to 10
9 CFU) were transformed
by electroporation using 1 to 3 mg of plasmid DNA, as described
previously [20]. After 3 hours incubation in non-selective medium,
cells were allowed to grow in the presence of appropriate antibiotic
for 24 hours before plating on selective solid medium. Transfor-
mants were picked after 4 to 7 days and subcultured in selective
SP4 medium. The expression of M. agalactiae surface antigen P40
was tested by Western blotting.
Western blotting and immunodetection of M. agalactiae
lipoprotein P40
Mycoplasmas grown in SP4 medium were collected by
centrifugation at 10,0006 g and resuspended in Dulbecco’s
phosphate-buffered saline (Invitrogen). The protein concentration
was determined using the Quick Start Bradford protein assay (Bio-
Rad). For Western blotting, total proteins (0.5 mg) were separated
by SDS-PAGE using the Mini-Protean II electrophoresis system
(Bio-Rad) and transferred to Protran nitrocellulose membranes
(Whatman). Membranes were blocked in Tris-buffered saline
(TBS) (10 mM TrisHCl, pH 7.4; 150 mM NaCl) containing 5%
skim milk for 2 hours, then incubated overnight at 4uC with a
sheep anti-P40 serum at a dilution of 1/500 in TBS containing
0.05% Tween 20 and 10% heat-inactivated horse serum
(Invitrogen). Western blots were developed using horseradish
peroxidase conjugated secondary antibody raised in rabbits
(DAKO) and 4-chloro-naphthol as substrate. Sheep serum raised
against the M. agalactiae surface antigen P80 was used as a control
(dilution of 1/200). The anti-P40 and anti-P80 sheep sera were
produced by animal immunization with P40 or P80 recombinant
proteins, respectively (data not shown).
Results and Discussion
High-throughput identification of M. agalactiae growth-
deficient mutants upon co-cultivation with host cells
Our group has previously reported the construction of a library
of M. agalactiae knockout mutants together with the development of
a high-throughput screening method based on the co-cultivation of
M. agalactiae mutants with HeLa cells [20]. Since human epithelial
cells are not a natural environment for M. agalactiae,w e
subsequently screened the library with two caprine cell lines,
which are likely to be more relevant to the normal host-cell
interactions involved in infections with this pathogen. The goat
mammary epithelial cells, TIGMEC, are likely to be particularly
relevant given the predilection of M. agalactiae for the mammary
gland. HeLa cells were used as a control.
The ability of individual mutants to grow in the presence of
these three cell lines was assessed after 3 days of co-cultivation by
Table 1. Oligonucleotides used in this study.
Name Sequence (59R39)
SG5 TTTTACACAATTATACGGACTTTATC
SG8 GAGTCAGTGAGCGAGGAAGC
P40_RF_CC ACGGGGCTAAAGAAGCTGAT
CCP40-03 TGGTTATATTTTCCATATCTTTC
Pip-P40_F GCAATTGAGAATTTTATTAAAGG
ATAAATA-ATGAAAACAAATAGA
AAAATATTGTTTGGT
Pip-P40_R ACCAAACAATATTTTTCTATTT
GTTTTCAT-TATTTATCCTTTA
ATAAAATTCTCAATTGC
Pip-86804_F GCCAGCCATATGGTGCATATTTAG
Pip_F TATTCGACCAAAGAGGGTGT
Pip_R TCATCAAAATCACCACCAAG
NifS_F1 TCAGCCGACATTATTCATGG
NifS_R1 CACCGGCTTTTAATTTTTGC
NifS_F2 TGTCACAAAGTTGGAGCAAT
NifS_R2 ACGAAGGAATCGTTACAAGC
NifU_F AGGGTTTCGCTAGGGGTTTA
NifU_R CTGTGCGCGCTTACAAAGTA
59-6FAM-NifS1
a TAGTTCTTGTGCTAACCGAATA
aOligonucleotide labeled by a 6-carboxyfluorescein (FAM) 59-modification.
doi:10.1371/journal.pone.0025291.t001
Table 2. High-throughput detection of M. agalactiae mutants
unable to grow on cultured cells.
Cut-off value (CFU titers)
a TIGMEC
b TIGEF HeLa
0 (10
4 CFU/ml) 15 (0.7%)
c 15 (0.7%) 25 (1.1%)
10 (10
5 CFU/ml) 26 (1.2%) 96 (4.4%) 153 (7.0%)
aThe cut-off value is the number of colonies counted on solid medium
following 3 days co-cultivation of M. agalactiae knockout mutants with cells.
Titers in parentheses indicate the predicted titers in the co-culture.
bNumber of M. agalactiae growth deficient mutants selected on goat mammary
epithelial cells (TIGMEC), goat embryonic fibroblast cells (TIGEF), and HeLa cells
(HeLa).
cPercentage of growth deficient mutants selected from the mutant library.
doi:10.1371/journal.pone.0025291.t002
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the titers (see Materials and Methods). A total of 209 growth-
deficient mutants were selected out of 2,175 tested, using a cut-off
value of 10 colonies per plate, which corresponded to a titer of
10
5 CFU/ml in co-cultures (Table 2). The mutants unable to grow
in each cell line are shown in Fig. 1A, with a detailed description of
those unable to grow on caprine cells provided in Tables 3 and 4.
Some differences were seen between the repertoire of mutants
identified as growth deficient on HeLa cells in the current study
and those identified in our previous study [20], with only 61%
common to both studies. This reflects the limitations of these
assays, including some cross contamination between individual
mutants stored in 96-well plates. These were found to hamper the
selection of mutants with reduced growth capacities in cell culture
(data not shown) and to affect the reproducibility of the screening
from one experiment to the other.
Some mutants (27%) displayed reduced growth capacities on
multiple cell types, while the majority (73%) exhibited this phenotype
on one cell line (Fig. 1A). Interestingly, only a small number of
mutants were selected on TIGMEC, compared to the number
selected on TIGEF and HeLa cells (Table 2). It is possible that the
tolerance of M. agalactiae to transposon mutagenesis increases when
grown on a cell type similar to its natural environment, but this
hypothesis needsto be confirmed with alarger panel of host celltypes.
Figure 1. Overall distribution of M. agalactiae growth deficient mutants selected after co-cultivation with host cells. (A) Number of
mutants selected on goat mammary epithelial cells (TIGMEC), goat embryo fibroblasts (TIGEF) and/or HeLa cells. (B) Number of unique transposon
insertion sites identified in mutants selected for their inability to grow on TIGMEC and/or TIGEF. Some mutants had the same insertion site. (C)
Distribution in COG categories of the 46 CDSs found disrupted in growth deficient mutants selected on caprine cells (see panel B) [38]. Multiple COG
proteins include MAG1490 and MAG2120, which fall into several COG categories (energy production and conversion, C-COG, coenzyme transport and
metabolism, H-COG and general function prediction only, R-COG for MAG1490; general function prediction only, R-COG, signal transduction
mechanisms, T-COG, transcription, K-COG and replication, recombination and repair, L-COG, for MAG2120).
doi:10.1371/journal.pone.0025291.g001
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CDS name
a Cells
b
No. of
mutants (no.
of insertion
sites)
c
% CDS
(orientation)
d Gene Gene product (COG)
e
Predicted
Localization
f
Detected by
MS/MS
g
MAG0490 F 1 (1) 0.62 (2) CHP M 2
MAG0640 F 1 (1) 0.71 (2) asnA Aspartate-ammonia ligase (E) C 2
MAG0720 E, F * 2 (2) 0.18 (2)/1.00 (+) nifS Cysteine desulfurase (E) C 2
MAG0890 E, F * 2 (1) 0.85 (+) hprK Hpr kinase phosphorylase (T) C +
MAG1180 E, F * 1 (1) 0.95 (2) pepP XAA-PRO aminopeptidase (E) C +
MAG1330 F * 1 (1) 0.31 (2) CHP DUF285 family, predicted lipoprotein M 2
MAG1430 E, F * 6 (3) 0.15 (+)/0.84 (+)/
0.85 2 0.95 (2)
HP M +
MAG1490 F * 1 (1) 0.86 (2) ldhD D-lactate dehydrogenase (CHR) IM +
MAG1500 F 2 (1) 0.56 (+) Esterase lipase (R) C 2
MAG1540 F * 1 (1) 0.27 (2) tig Trigger factor (O) C +
MAG1740 F 1 (1) 0.32 (2) gidA Glucose-inhibited division protein A (D) C +
MAG1860 F * 1 (1) 0.63 (2) gidB Methyltransferase GidB (M) C 2
MAG1890 F 1 (1) 0.11 (2)H P M +
MAG2110 E 1 (1) 0.08 (+) Protein phosphatase (T) C 2
MAG2120 E, F * 1 (1) 0.53 (2) pknB Serine/threonine-protein kinase (RTKL) M +
MAG2540 F * 20 (1) 0.57 (2) HP, Vpma-like, predicted lipoprotein M +
MAG2680 F * 1 (1) 0.60–0.70 (2)H P M +
MAG2870 F * 2 (2) 0.16 (2)/0.72 (+) CHP, predicted lipoprotein M 2
MAG2930 E * 1 (1) 0.01 (2) atpA ATP synthase a ´ chain (C) IM +
MAG2960 F * 1 (1) 0.17 (2) CHP, predicted lipoprotein M 2
MAG3030 F 3 (1) 0.31 (+)H P M 2
MAG3350 F * 1 (1) 0.18 (2)H P M 2
MAG3370 F 1 (1) 0.72 (2) CHP M 2
MAG3480 F * 1 (1) 0.70 (2)H P C +
MAG3720 E, F 1 (1) 0.10 (+) CHP IM 2
MAG3740 F * 1 (1) 0.2–0.4 (+) mraZ MraZ (S) IM 2
MAG3790 E, F * 10 (1) 0.95 (2) uvrA UvrABC system protein A (L) C +
MAG3860 F * 1 (1) ND (2) CHP IM 2
MAG4200 F 1 (1) 0.97 (+) CHP C 2
MAG4380 F * 3 (2) 0.50–0.75 (2)/
0.88 (+)
P115-like ABC transporter ATP
binding protein (D)
C +
MAG4650 E 1 (1) 0.98 (2) Phosphomannomutase (G) C +
MAG4740 F 1 (1) 0.11 (+) HP, predicted lipoprotein M +
MAG4820 E 2 (1) 0.97 (2) CHP (M) C 2
MAG4950 E, F * 1 (1) 0.79 (2) HP, predicted lipoprotein M 2
MAG5000 F 4 (1) 0.22 (+)H P M 2
MAG5150 F * 1 (1) 0.91 (2) HP, predicted lipoprotein M +
MAG5910 F 1 (1) 0.72 (+)5 9 nucleotidase, predicted lipoprotein (F) M +
MAG6090 F 1 (1) 0.96 (2) HP, predicted lipoprotein M 2
MAG6450 E 1 (1) 0.87 (+) CHP C 2
MAG6690 F 1 (1) 0.67 (2)H P M 2
MAG6760 F 1 (1) 0.07 (2) chrA Chromate transport protein (P) M 2
MAG6770 F * 1 (1) 0.99 (2) chrA Chromate transport protein (P) M +
MAG6870 F 2 (2) 0.60 (2)/0.70 (2) dnaX DNA polymerase III subunits
gamma and tau (L)
C +
MAG6960 E, F * 1 (1) 0.58 (2) apt Adenine phosphorybosyltransferase (F) C +
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PLoS ONE | www.plosone.org 5 September 2011 | Volume 6 | Issue 9 | e25291Mapping of transposon insertion sites in the genome of
growth-deficient M. agalactiae mutants
Direct genomic sequencing was performed to determine the
position of the transposon in mutants found to be inhibited on
caprine cell lines. The 110 mutants had 62 unique insertion sites
that mappedwithin46different coding sequences (CDS) and 9 non-
coding regions (NCR) (Fig. 1B and Tables 3, 4). The examination of
DNA sequence chromatograms failed to reveal multiple transposon
insertion events in the M. agalactiae chromosome (data not shown).
As shown in Figure 1C, most of the disrupted CDSs have been
annotated as hypothetical proteins (HP) of unknown function (no
COG). Within this category, predicted surface lipoproteins were
highly represented 2.1 times more than would be expected [6].
Because of the absence of a cell wall in mycoplasmas, cell surface
lipoproteins are thought to be key players in modulating
interactions with the host. Interestingly, 20 mutants with a
disruption in the same lipoprotein gene (MAG2540) were inhibited
on the TIGEF, but not the TIGMEC (Table 3). All had the
transposon inserted at the same position, suggesting that they were
probably siblings derived from the same parental clone. The
repeated selection of this particular mutant suggests a role for
MAG2540 in the proliferation of M. agalactiae on TIGEF, even
though it is dispensable in axenic culture medium and in the
presence of TIGMEC. The function of this CDS is unknown, but
it is predicted to encode a surface lipoprotein (Vpma-like
lipoprotein) with similarities to some domains of the hypervariable
Vpma lipoproteins of M. agalactiae [24]. Because MAG2540
CDS name
a Cells
b
No. of
mutants (no.
of insertion
sites)
c
% CDS
(orientation)
d Gene Gene product (COG)
e
Predicted
Localization
f
Detected by
MS/MS
g
MAG7100 F 1 (1) 0.56 (2) vpmaZ Variable surface lipoprotein D (VpmaZ
precursor)
M +
MAG7200 F 1 (1) 0.74 (+) scpB Segregation and condensation protein B (K) C +
aCDS found disrupted in M. agalactiae growth-deficient mutants [6].
bLetters E and F indicate that the M. agalactiae growth-deficient mutants were selected on TIGMEC or TIGEF cells, respectively. Asterisks (*) indicate mutants that were
also selected during high-throughput screening on HeLa cells.
cFor each CDS, the number of mutants identified during the screening on caprine cell lines is indicated, as well as the number of different mini-Tn insertion sites.
dFor each CDS, the relative position and the orientation of the inserted transposon are indicated. Mini-Tn insertion sites were determined by direct sequencing of
genomic DNA, and their positions were defined based on the published genome sequence (NC_009497).
eHypothetical proteins (HP) have no homolog outside the species M. agalactiae. Conserved hypothetical proteins (CHP) share sequence similarity with proteins of
unknown function identified in other Mollicutes or other bacteria. COG categories of encoded proteins are indicated in parentheses [38].
fProtein localization was predicted using TMHMM [41,42]; membrane (M), cytosolic (C), or indirectly linked to the membrane (IM).
gProteins with peptides detected during proteomic analysis of gene products expressed by M. agalactiae strain PG2 in axenic culture are identified by a plus sign (+),
while proteins not detected are identified by a minus sign (2) [32].
doi:10.1371/journal.pone.0025291.t003
Table 3. Cont.
Table 4. M. agalactiae NCRs identified by high-throughput screening with host cells.
Name
a Cells
b
No. of mutants
(no. of insertion
sites)
c Size of NCR
Genomic position
(orientation)
d Genetic environment of NCR
e
NCR A F 1 (1) 67 nt 31900 (+) HP (MAG0310) and HP (MAG0320)
NCR B E, F * 7 (1) 676 nt 388694 (+) ptsG (MAG3250) and CHP DUF285 family (MAG3260)
NCR C E, F * 2 (1) 740 nt 402664 (+) HP (MAG3390) and CHP (MAG3400)
NCR D F 1 (1) 351 nt 460191 (+) Pseudogene of CHP (MAG3880) and pseudogene of CHP (MAG3890);
vestige of ICEA
NCR E F * 1 (1) 423 nt 469389 (+) HP (MAG3950) and CHP (MAG3960); AMIGene CDS prediction of 52 AA
(from 469474 to 469319); vestige of ICEA
NCR F F * 2 (1) 330 nt 473081 (+) HP (MAG4010) and HP (MAG4020); vestige of ICEA
NCR G E 1 (1) 802 nt 648734 (2) gyrA (MAG5630) and hsdS (MAG 5640); AMIGene CDS prediction of 67
AA (from 648894 to 648694)
NCR H F 1 (1) 290 nt 761860 (2) HP (MAG6430) and putative prophage protein ps3 (MAG6440)
NCR I F * 2 (2) 80 nt 843595 (+)/843634 (+) cmk (MAG7250) and HP (MAG7260)
aNCRs were labeled with a letter based on their position in the genome of M. agalactiae.
bLetters E and F indicate NCRs carrying insertions in mutants with reduced growth capacities on TIGMEC and/or TIGEF, respectively. Asterisks (*) indicate mutants that
were also selected during high-throughput screening on HeLa cells.
cFor each NCR, the number of mutants identified during the screening with caprine cells is indicated, as well as the number of insertion sites.
dTransposon insertion sites were determined by direct sequencing of genomic DNA and their positions were defined based on the published genome sequence
(NC_009497). The orientation of the transposon is indicated in parentheses.
eSurrounding CDS and mini-Tn disrupted AMIGene CDS predictions; CDS names are given in parenthesis; vestige of ICEA indicates an NCR located within a 20 kb locus
containing a vestige of an integrative conjugative element (ICEA).
doi:10.1371/journal.pone.0025291.t004
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possible that, in the absence of specific receptors on target cells
such as the TIGMEC, this Vpma-like lipoprotein facilitates
binding to ubiquitous structures on mammalian cell surfaces. This
implies that growth of M. agalactiae in cell cultures requires a close
interaction with the cells that is lost in the MAG2540 knockout
mutants when growing on TIGEF or HeLa cells. As expected for
bacteria with small genomes and reduced metabolic pathways,
‘‘transport and metabolism’’ (COG categories E, F, G, H and P)
was the largest functional category involved in interactions
between M. agalactiae and caprine cells, with 17% of the mutants
selected having insertions in genes involved in these functions
(Fig. 1C). Since the wild-type is unable to proliferate in cell-culture
medium alone [20], it is most likely that these mutants are unable
to transport or metabolize some of essential nutrients provided by
the cultured cells. The remaining CDSs for which a predicted
function had been assigned were distributed across a broad range
of functional categories (Fig. 1C), often without any predictable
correlation with their role in interactions with caprine cells.
Some of the loci identified in mutants selected on caprine cell
lines (Tables 3 and 4), were also identified as being required for
growth on HeLa cells, either in this study (Tables 3 and 4) or in
our previous study [20]. This suggests that these loci may be
involved in general processes mediating interactions between M.
agalactiae and mammalian cells. The functions encoded by several
of these, including DNA repair (uvrA), nucleotide metabolism (apt),
iron-sulfur cluster biosynthesis (nifS), and protein folding (tig),
contribute to stress tolerance and virulence in a number of
pathogenic bacteria [25–31].
A global proteomic analysis of gene products expressed by M.
agalactiae strain PG2 in axenic culture [32] detected approximately
50% of the CDSs found to be required for growth on caprine cells
(Table 3). Whether this reflects the limited sensitivity of the
proteomic approach, or differential expression by M. agalactiae
under axenic and co-culture conditions is not known.
About 20% of the mutants selected on caprine cells had an
insertion in a NCR (Table 4). The importance of NCRs in the
biology of M. agalactiae remains largely unexplored, but several are
likely to include transcriptional promoters and other regulatory
regions. Re-examination of the 9 mutated NCRs using the
AMIGene annotation tool [33] revealed that two, NCR E and G,
had an insertion within short CDSs (Table 4) that had not been
annotated previously but that could encode products with a role in
host-cell interaction. Interestingly, transcriptional activity in NCRs
has been reported for a number of mycoplasmas [34,35],
suggesting an active role for these regions. NCRs D, E and F
(Table 4) are part of a 20 kb locus containing a vestige of an
integrative conjugative element (ICEA) [6,36]. The mechanism by
which NCRs may regulate the proliferation of M. agalactiae in cell
culture remains to be elucidated.
Finally, several CDSs required for growth on host cells are
conserved in other ruminant mycoplasma species, and/or were
involved in the massive horizontal gene transfer (HGT) that
occurred between M. agalactiae, M. bovis and members of the
phylogenetically distant mycoides cluster (Table S1). Two CDSs
(MAG2870 and MAG6690) were also predicted to have
undergone HGT between the avian mycoplasma species M.
synoviae and M. gallisepticum (Table S1). About 70% of these CDSs
involved in HGT encode membrane-associated proteins, and thus
are likely to play a role in mycoplasma–host interactions. The
genome-scale analysis of M. agalactiae in cell culture may assist in
understanding pathogenic processes involved in other mycoplasma
infections.
The frequent occurrence of promoter regions in the
genome of M. agalactiae reduces polar effects mediated
by integrated transposon sequences
As mentioned above, some CDSs required for growth on cell
cultures fell into functional categories (Fig. 1C) that had no
obvious correlation with mycoplasma-host interactions. This
raised the question of whether growth-deficient phenotypes can
result from a polar downstream effect rather than the effect on the
gene disrupted by the transposon insertion. The compact
mycoplasma genome, which is often organized into highly dense
co-linear gene clusters with operon-like structures, suggests that
this might be likely [3].
To evaluate the potential influence of the mini-Tn insertions
on gene expression from these operon-like structures, we
analyzed the 4 kb co-linear gene cluster pip-nifS-nifU-mucB
(MAG0710 to MAG0740) (Fig. 2). This cluster was of particular
interest because: (i) nifS has been shown to be essential for
proliferation of M. agalactiae on cell cultures, and two knockout
mutants, NifS1 and NifS2, were identified by high-throughput
screening on caprine and human cells (Table 3); and (ii) these co-
linear genes are likely to be co-transcribed by a promoter located
upstream of pip, based on genome data indicating short intergenic
distances (Fig. 2A). Indeed, the operon-like structure of the pip-
nifS-nifU-mucB cluster was further supported by our transcrip-
tional analyses, which detected overlapping transcripts by RT-
PCR (Fig. 2A). Two mutants, Pip and MucB, with a transposon
inserted into the corresponding genes, were searched for and
found in the mutant library (see Materials and Methods), but
both are able to grow on all three cell lines. When tested
individually with TIGMEC, both mutants had the wild-type
phenotype (Fig. 2B). This result was surprising, at least for the Pip
mutant, which was expected to have a similar phenotype to that
of the NifSs mutants because of the predicted polar effect of the
transposon insertion (Fig. 2A).
RT-PCR amplification using oligonucleotide primers bracket-
ing the mini-Tn integration site in mutants Pip, NifS1, and NifS2
did not detect mRNA (RT-PCR II in mutants Pip and NifS1, and
RT-PCR IV in mutant NifS2), but, unexpectedly, transcripts were
detected downstream of the mini-Tn (RT-PCR III and IV in
mutants Pip and NifS1), suggesting that there may be a promoter
within pip or the mini-Tn. The presence of a promoter within the
integrated mini-Tn sequences was suggested by the identification
of RNA transcripts that overlapped the 39 end of the mini-Tn and
nifS in Pip and NifS1 mutants (data not shown). The extension of
transcription beyond the 39 end of the mini-Tn was probably
responsible for the expression of downstream genes in knockout
mutants of M. agalactiae and may have influenced the orientation of
the mini-Tn in the mutant library [20]. Although promoter
sequences in the mini-Tn remain to be formally demonstrated,
constitutive gene expression from the 39 end of the mini-Tn can
also be viewed as another outcome of transposon mutagenesis.
Experiments are in progress to determine the role of this
mechanism in mutants unable to grow in cell cultures that harbor
a transposon within a NCR.
Recent studies on Mycoplasma genitalium have revealed that the
genome of this human pathogen is actively transcribed, and
contains multiple cryptic promoters [34]. This led us to further
explore transcriptional activity within the pip-nifS-nifU-mucB
cluster, and to examine the promoter activity at the 39 end of
the pip gene. A reporter system was developed to detect promoter
sequences in M. agalactiae (Fig. 2C). Lipoprotein P40 (MAG2410) is
a surface antigen of M. agalactiae, the expression of which can be
detected using specific antibodies. The successful complementa-
tion of a M. agalactiae mutant, P40 minus, harboring a transposon
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led us to develop a reporter system to detect promoter activity.
Western blotting analyses confirmed that the 157 nucleotides at
the 39 end of the pip gene, when inserted at the 59 end of the P40
lipoprotein gene, promote complementation of the P40 minus
mutant.
Finally, the transcriptional start point at the 39 end of the pip
gene was mapped by primer extension using the oligonucleotide
59-6FAM-NifS1 (Table 1). A major extension product with a size
of between 163 and 165 nucleotides was obtained, indicating that
the transcriptional start point was 31 nucleotides upstream of the
stop codon of the pip gene (Fig. 2D). The detection of multiple
Figure 2. The nif locus in M. agalactiae is a promoter-less CDS cluster inserted within a transcriptionally active region. (A) Schematic
representation of the 4 kbp co-linear gene cluster pip-nifS-nifU-mucB indicating the four regions amplified by RT-PCR. Intergenic distances in
nucleotides are indicated below. Transposon insertion sites are indicated by filled circles using a different color code for each mutant. RNA regions
amplified by RT-PCRs I to IV are indicated by black bars. The promoter identified in the 39 end of pip is indicated by a black arrow. (B) Bar graph
indicating the titers obtained, after cultivation in axenic media or in the presence of TIGMEC, of M. agalactiae strain PG2 or mutants NifS1, NifS2, Pip
and MucB. Titers were determined after 48 h cultivation in axenic medium and after 72 h co-cultivation with TIGMEC. The bars indicate the means of
three independent assays, with standard deviations indicated by error bars. (C) Identification of promoter sequences in M. agalactiae using a new
reporter system. The surface antigen P40-knockout mutant (mutant P40 minus) was complemented using plasmid constructs containing the P40
coding sequence preceded by its own promoter (a), without a promoter (b), or preceded by the 39 end of pip (c). The expression of the P40 antigen
was detected by Western blotting. The surface antigen P80 was used as control. (D) Chromatogram obtained after primer extension of total RNA
extracted from a M. agalactiae PG2 culture with primer 59-6FAM-NifS1 (Table 1) as described in the Materials and Methods. Red peaks correspond to
the GS-400HD ROX internal lane standards and the shaded blue peaks to the primer extension product. The size is indicated on the X-axis in base
pairs. The peak height indicates the fluorescence intensity (arbitrary units) with GS-400HD ROX fluorescence measured on the right Y-axis and FAM
fluorescence on the left Y-axis. The position of the transcriptional start point in CDS MAG0710 (pip) identified by primer extension experiments is
indicated. Putative 210 and 235 regions are underlined. The transcriptional start points are indicated in bold.
doi:10.1371/journal.pone.0025291.g002
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common finding in mycoplasma promoters [34,37].
The genomes of mycoplasmas are characterized by a low G+C
content. This particular feature may favor the occurrence of
primary or secondary promoter regions in the genome of M.
agalactiae, even within coding sequences such as this promoter
within the 39 end of the pip gene. The high density of promoters
within the genome of M. agalactiae may have important
evolutionary consequences, facilitating chromosomal rearrange-
ments and gene shuffling in these rapidly evolving organisms.
Gene involved in the interaction of M. agalactiae with
host cells may have been hitchhiking across evolution
Although polar effects resulting from the disruption of co-
transcribed gene clusters cannot be ruled out, the identification of
multiple transposon insertion sites in the same region suggests that
important factors mediating the interaction between M. agalactiae
and host cells may map to these loci. Among the 62 loci identified
after screening with host cells, six loci mutants had insertions in the
same CDS or NCR, but at different positions (Tables 3 and 4).
CDSs with multiple insertion sites included two HP predicted to
be exposed on the cell surface (MAG1430 and MAG2870), and
cytosolic proteins with homologies with cysteine desulfurase
(MAG0720), the P115-like ABC transporter ATP binding protein
(MAG4380), and DNA polymerase III subunits gamma and tau
(MAG6870). Only one NCR (NCR I) was found containing two
different insertions that inhibited the capacity of M. agalactiae to
grow on host cells. Interestingly, CDSs MAG0720 (nifS) and
MAG6870 (dnaX) each belong to co-linear gene clusters (Fig. 3)
that are highly conserved in Mollicutes (Fig. S1, S2, and S3). The
remarkable conservation of these two gene clusters led us to
examine the co-localization of the 46 CDS identified as being
required for growth of M. agalactiae on cultured cells, and to
compare the synteny of these CDSs using complete genome
sequences of mycoplasmas available in public databases. A total of
8 highly conserved co-linear gene clusters were identified (Fig. 3
and Fig. S1, S2, and S3). Several of these clusters encode proteins
predicted to be involved in specific functions, including [Fe-S]
cluster biosynthesis (NIF), chromate transport (CHR), cell division
(MRAZ) and DNA replication, recombination and repair
(DNAX). The potential role of these CDS clusters in the
interaction between M. agalactiae and host cells was further
supported by the similar effect of transposon insertions at different
positions in these CDS clusters (NIF, PKNB, MRAZ, CHR and
DNAX in Fig. 3). The essential role of the NIF locus in the
interaction between M. agalactiae and host cells has been
demonstrated previously by complementation studies [20].
The location of these CDS clusters can differ considerably from
one mycoplasma species to another, even within the same
phylogenetic group (Fig. S1, S2, and S3). In M. agalactiae,
promoter sequences initiating the transcription of nifS were located
outside of the NIF locus, with a sequence identified within the 39
end of the pip gene (see above). Interestingly, the pip gene does not
always co-localize with the NIF locus in other mycoplasma species,
suggesting that this locus is inserted within transcriptionally active
regions. Thus, it is tempting to speculate that some of the genes
involved in the interaction between M. agalactiae and host cells may
have been hitchhiking across evolution for transcriptionally active
regions of the mycoplasma chromosome. Further evidence is
needed to support this hypothesis.
In conclusion, cell culture provides a simple and efficient
screening system for genome-scale analysis of mycoplasma loci
Figure 3. Genomic loci carrying transposon insertions in M. agalactiae mutants displaying reduced growth capacities in cell culture.
Map of the 62 genomic regions found to be disrupted in M. agalactiae mutants selected on TIGMEC and/or TIGEF cells, produced using the Artemis
genome browser and annotation tool [39]. Insertion sites found within CDS regions are indicated by a blue bar, while intergenic regions are
designated by a letter code and a purple bar. Short CDS clusters are designated by capital letters and a schematic illustration of the locus, in which
insertion sites are indicated by a filled circle on top of a blue bar. Genes are labeled. CDSs for hypothetical proteins of unknown function are labeled
with their gene number. Genomic distances are indicated in kbp. M. agalactiae CDSs are colored in green (positive) or red (negative) on the
chromosome to indicate their orientation. Non-coding RNAs are colored in black.
doi:10.1371/journal.pone.0025291.g003
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when combined with in vivo studies, can be an efficient strategy for
identifying key factors involved in mycoplasma virulence and host-
colonization, as well as a way to understand pathogenic processes
involved in disease caused by these unconventional pathogens.
The absence of small animal models for M. agalactiae and other
ruminant mycoplasmal pathogens has been a significant bottle-
neck for functional genomics studies using large mutant libraries.
High-throughput screening of more than 2000 individual clones
by co-culture with host cells revealed 62 loci in the genome of M.
agalactiae that were required for growth in this environment. The
relevance of these loci in the biology of M. agalactiae when it
replicates in its natural host remains to be determined, but
experimental infections in lactating ewes have confirmed the
essential role played by nifS in host-colonization (data not shown).
Since the specific cell line was shown to influence which mutants
were selected, comparative studies with different cell types,
including differentiated monolayer cultures and cellular players
involved in the immune response to infection, may provide further
information about the interactions of mycoplasmas in these
different cellular environments. Finally, these results provide an
experimental framework for the development of control strategies,
based on attenuated live vaccines, against mycoplasmosis in
ruminant species.
Supporting Information
Figure S1 Genomic position of short CDS clusters NIF,
HPRK, MRAZ and CHR in mycoplasma species with
sequenced genomes. Gene organization of the conserved CDS
clusters identified during the screening was analyzed using the
Microbial Genome Database for Comparative Analysis software
[40]. Homologues genes are indicated by the same color code and
a black bar. Three examples were chosen for each phylogenetic
group. In the case of the CHR locus, no homolog was identified in
the Pneumoniae group. MA: M. agalactiae, MMOB: M. mobile,
MYPU: M. pulmonis, MLEA: M. leachii, MmmSC: Mycoplasma
mycoides subsp. mycoides SC, MCAP: M. capricolum subsp. capricolum,
UPAR: U. parvum, UURE: U. urealyticum, MGAL: M. gallisepticum.
(TIF)
Figure S2 Genomic position of short CDS clusters
PKNB and ATP in mycoplasma species with sequenced
genomes. Gene organization of the conserved CDS clusters
identified during the screening was analyzed using the Microbial
Genome Database for Comparative Analysis software [40].
Homologues genes are indicated by the same color code and a
black bar. Three examples were chosen for each phylogenetic
group. MA: M. agalactiae, MMOB: M. mobile, MYPU: M. pulmonis,
MLEA: M. leachii, MmmSC: Mycoplasma mycoides subsp. mycoides
SC, MCAP: M. capricolum subsp. capricolum, UPAR: U. parvum,
UURE: U. urealyticum, MGAL: M. gallisepticum.
(TIF)
Figure S3 Genomic position of short CDS clusters
DNAX and SCPB in mycoplasma species with sequenced
genomes. Gene organization of the conserved CDS clusters
identified during the screening was analyzed using the Microbial
Genome Database for Comparative Analysis software [40].
Homologues genes are indicated by the same color code and a
black bar. Three examples were chosen for each phylogenetic
group. MA: M. agalactiae, MMOB: M. mobile, MYPU: M. pulmonis,
MLEA: M. leachii, MmmSC: Mycoplasma mycoides subsp. mycoides
SC, MCAP: M. capricolum subsp. capricolum, UPAR: U. parvum,
UURE: U. urealyticum, MGAL: M. gallisepticum.
(TIF)
Table S1 Degree of homology of CDS disrupted in M.
agalactiae mutants with other ruminant mycoplasma
species.
aCDS found disrupted in M. agalactiae growth-deficient
mutants [6].
bHypothetical proteins (HP) have no homolog outside
the M. agalactiae species. Conserved hypothetical proteins (CHP)
share sequence similarity with proteins of unknown function
identified in mollicutes or other bacteria. COG categories of
encoded proteins are indicated in parenthesis [38].
cProtein
localization was predicted using TMHMM [40]; membrane (M),
cytosolic (C), or indirectly linked to the membrane (IM).
dGenes
supposed to have undergone horizontal gene transfer (HGT)
between M. agalactiae and mycoplasmas from the mycoides
cluster [6] are indicated by a plus sign (+). Genes displaying
homologies with sequences in M. gallisepticum or M. synoviae
genomes and supposed to have undergone HGT between these
two species are identified by a cross sign (x) [6].
ePercentages of
identity and similarity were determine by local BLAST using
Molligen [42].
fMCAP stands for M. capricolum subsp. capricolum.
(DOC)
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